Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Binary MoS2 nanostructures as nanocarriers for amplification in multiplexed electrochemical immunosensing: simultaneous determination of B cell activation factor and proliferation-induced signal immunity-related cytokines. | Mikrochim Acta | 2022 | 35286499 | PubTator, text mining | PubMed |
| When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies. | Front Oncol | 2022 | 35280746 | PubTator, text mining | PubMed |
| Advances in local therapy for glioblastoma - taking the fight to the tumour. | Nat Rev Neurol | 2022 | 35277681 | PubTator, text mining | PubMed |
| Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort. | Eur Respir J | 2022 | 35273030 | PubTator, text mining | PubMed |
| An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy. | BMC Cancer | 2022 | 35272617 | PubTator, text mining | PubMed |
| Innovating Strategies and Tailored Approaches in Neuro-Oncology. | Cancers (Basel) | 2022 | 35267432 | PubTator, text mining | PubMed |
| Immunotherapy Associated Neurotoxicity in Pediatric Oncology. | Front Oncol | 2022 | 35265526 | PubTator, text mining | PubMed |
| CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future. | Front Immunol | 2022 | 35265074 | PubTator, text mining | PubMed |
| Cell-based immunotherapy of glioblastoma multiforme. | Oncol Lett | 2022 | 35251352 | PubTator, text mining | PubMed |
| INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer. | Breast Cancer Res | 2022 | 35248133 | PubTator, text mining | PubMed |
| Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients. | Ann Intensive Care | 2022 | 35246776 | PubTator, text mining | PubMed |
| The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy. | BMC Gastroenterol | 2022 | 35246045 | PubTator, text mining | PubMed |
| Engineering autonomous closed-loop designer cells for disease therapy. | iScience | 2022 | 35243222 | PubTator, text mining | PubMed |
| The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors. | J Neurooncol | 2022 | 35235137 | PubTator, text mining | PubMed |
| Atopic Dermatitis Pathogenesis: Lessons From Immunology. | Dermatol Pract Concept | 2022 | 35223190 | PubTator, text mining | PubMed |
| An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip. | Int J Mol Sci | 2022 | 35216228 | PubTator, text mining | PubMed |
| Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19. | Viruses | 2022 | 35215943 | PubTator, text mining | PubMed |
| An Overview of Nanotechnologies for Drug Delivery to the Brain. | Pharmaceutics | 2022 | 35213957 | PubTator, text mining | PubMed |
| Ferroptosis Involvement in Glioblastoma Treatment. | Medicina (Kaunas) | 2022 | 35208642 | PubTator, text mining | PubMed |
| Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond. | Cancers (Basel) | 2022 | 35205812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=43